The Leukemia & Lymphoma Society, Inc. 403(B) Plan — Form 5500 plan (The Leukemia & Lymphoma Society, Inc. 403(B) Plan)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, The Leukemia & Lymphoma Society, Inc. 403(B) Plan is a benefit plan reported by The Leukemia & Lymphoma Society, Inc. 403(B) Plan under EIN 13-5644916 and plan number 002. The latest loaded filing year is 2023. The filing reports 1,596 participants and $117,472,817 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
The Leukemia & Lymphoma Society, Inc. 403(B) Plan
EIN
13-5644916
Plan number
002
Plan type
2
Location
Rye Brook, NY
Latest filing year
2023
Participants
1,596
End-of-year plan assets
$117,472,817

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
20231,596H, C20241002123048NAL0004006915001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$117,472,817
Total liabilities (EOY)
$0
Net assets (EOY)
$117,472,817
Net assets (BOY)
$97,208,416

Income & contributions

Employer contributions
$3,123,883
Participant contributions
$6,800,006
Total contributions
$10,706,407
Total income / additions
$27,874,520

Expenses & distributions

Benefits paid
$7,332,861
Administrative expenses
$238,819
Total expenses
$7,610,119
Net increase / (decrease)
$20,264,401

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Empower Annuity Insurance Company ORECORDKEEPER$139,604$02023
R.V. Kuhns & Associates, Inc.NONE$73,189not reported in the loaded dataset2023
Withum Smith+BrownNONE$26,000not reported in the loaded dataset2023

Related Form 5500 pages